Chenodeoxycholic Acid

ID: Reference9830

C₂₄H₄₀O₄

3α,7α-Dihydroxy-5β-cholan-24-oic acid; Anthropodeoxycholic Acid; CDCA; Fluibil; Hekbilin; Kebilis

(+/-)10(11)-EpDPA

ID: Reference9831

C₂₂H₃₂O₃

(4Z,7Z)-9-{(2S,3R)-3-[(2Z,5Z,8Z)-2,5,8-Undecatrien-1-yl]-2-oxiranyl}-4,7-nonadienoic acid; (+/-)-(4Z,7Z)-9-[3-(2Z,5Z,8Z)-2,5,8-undecatrien-1-yl-2-oxiranyl]-4,7-nonadienoic acid; (+/-)10,11-EDP; (+/-)10,11-EpDPE; (+/-)10,11-epoxy DPA; (+/-)10,11-epoxy Docosapentaenoic Acid

11(Z)-Eicosenoic acid

ID: Reference9832

C₂₀H₃₈O₂

(11Z)-11-Icosenoic acid; (11Z)-11-Eicosenoic acid; (11Z)-Icos-11-enoic acid; (11Z)-Icosenoic acid; (Z)-11-Eicosenic acid; (Z)-Eicos-11-enoic acid; (Z)-Icos-11-enoic acid

Tauroursodeoxycholic acid

ID: Reference9838

C₂₆H₄₅NO₆S

2-{[(3α,5β,7β)-3,7-Dihydroxy-24-oxocholan-24-yl]amino}ethanesulfonic acid; TUDA; TUDCA; N-Ursodeoxycholoyltaurine; Sodium tauroursodeoxycholate; Taurolite; Tauroursodeoxycholate

(+/-)8(9)-DiHET

ID: Reference9841

C₂₀H₃₄O₄

(5Z,8S,9R,11Z,14Z)-8,9-Dihydroxy-5,11,14-icosatrienoic acid; (+/-)8,9-dihydroxy-5Z,11Z,14Z-eicosatrienoic acid; (±)8,9-DiHETrE

Docosanoic acid

ID: Reference9848

C₂₂H₄₄O₂

Docosanoic acid; Glycon B-70; 1-Docosanoate; 1-Docosanoic acid; Behenic acid; Behensaeure; Docosanic acid

β-Muricholic acid

ID: Reference9852

C₂₄H₄₀O₅

(3α,5β,6β,7β)-3,6,7-Trihydroxycholan-24-oic acid; 5b-Cholanic acid-3a,6b,7b-triol; 5β-Cholanic acid-3α,6β,7β-triol; β-MCA; b-Muricholic acid; 3,6,7-Trihydroxy-5β-cholan-24-oic acid; 3a,6b,7b-Trihydroxy-5b-cholan-24-oate

20-hydroxy Leukotriene B4

ID: Reference9857

C₂₀H₃₂O₅

(5S,6Z,8E,10E,12R,14Z)-5,12,20-Trihydroxy-6,8,10,14-icosatetraenoic acid; 20-OH-LTB4; 5,12,20-THETE; 5,12,20-TRIHETE; (5R,12S,6Z,8E,10E,14Z)-5,12,20-Trihydroxy-6,8,10,14-icosatetraenoic acid; (5S,12R)-5,12,20-Trihydroxy-(6Z,8E,10E,14Z)-eicosatetraenoate; (5S,12R)-5,12,20-Trihydroxy-(6Z,8E,10E,14Z)-eicosatetraenoic acid

Bicyclo prostaglandin E2

ID: Reference9862

C₂₀H₃₀O₄

(Z)-7-[(1R,3aS,7aS)-4-Butyl-2,5-dioxo-3,3a,4,6,7,7a-hexahydro-1H-inden-1-yl]hept-5-enoic acid; (5Z,11β)-9,15-Dioxo-11,16-cycloprost-5-en-1-oic acid; 11-Deoxy-13,14-dihydro-15-keto-11β,16χ-cycloprostaglandin E2; 9,15-Dioxo-5Z-prostaenoic acid-cyclo[11S,16]; 5-Heptenoic acid,7-[(1R,3as,7as)-4-butyloctahydro-2,5-dioxo-1H-inden-1-yl]-,(5Z)-; Bicyclo PGE₂

(3R,5S)-1-(4-Pyridinylmethyl)-5-{3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazol-5-yl}-3-pyrrolidinol

ID: Reference9871

C₁₉H₁₇F₃N₄O₃

(3R,5S)-1-(Pyridin-4-ylmethyl)-5-[3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazol-5-yl]pyrrolidin-3-ol; 3-Pyrrolidinol, 1-(4-pyridinylmethyl)-5-[3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazol-5-yl]-, (3R,5S)-; NAT18-348770

(3R,5S)-1-(4-Fluorobenzyl)-5-[3-(4-methoxyphenyl)-1,2,4-oxadiazol-5-yl]-3-pyrrolidinol

ID: Reference9872

C₂₀H₂₀FN₃O₃

(3R,5S)-1-[(4-Fluorophenyl)methyl]-5-[3-(4-methoxyphenyl)-1,2,4-oxadiazol-5-yl]pyrrolidin-3-ol; 3-Pyrrolidinol, 1-[(4-fluorophenyl)methyl]-5-[3-(4-methoxyphenyl)-1,2,4-oxadiazol-5-yl]-, (3R,5S)-; NAT18-349424

(3R,5S)-1-(4-Methylbenzyl)-5-{3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazol-5-yl}-3-pyrrolidinol

ID: Reference9874

C₂₁H₂₀F₃N₃O₃

(3R,5S)-1-[(4-Methylphenyl)methyl]-5-[3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazol-5-yl]pyrrolidin-3-ol; 3-Pyrrolidinol, 1-[(4-methylphenyl)methyl]-5-[3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazol-5-yl]-, (3R,5S)-; NAT18-348775